High frequency of antidrug antibodies and association of random drug levels with efficacy in certolizumab pegol-treated patients with rheumatoid arthritis: results from the BRAGGSS cohort. (2017)

First Author: Jani M
Attributed to:  Centre for Integrated research into Musculoskeletal Ageing (CIMA) Renewal funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/annrheumdis-2015-208849

PubMed Identifier: 27245864

Publication URI: http://europepmc.org/abstract/MED/27245864

Type: Journal Article/Review

Volume: 76

Parent Publication: Annals of the rheumatic diseases

Issue: 1

ISSN: 0003-4967